{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}

Red Flags Detected

  • Collaboration Termination After Less Than One Year (new) — The Gemma agreement launched in July 2024 and was terminated by May 2026, suggesting the partnership failed to meet expectations or the company is pivoting strategy.
  • Office Exit With Termination Fee (new) — Paying $2.3M to exit a lease early, combined with prior subleasing, signals significant operational contraction and potential cash preservation efforts.
NASDAQ: PASG Passage BIO, Inc. 8-K

Passage Bio terminates Gemma collaboration, exits Philadelphia office for $2.3M fee

Filed May 27, 2026 · Period ending May 21, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade PASG commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 27, 2026 10:05 PM